|
1
|
Maniotis AJ, Folberg R, Hess A, et al:
Vascular channel formation by human melanoma cells in vivo and in
vitro: vasculogenic mimicy. Am J Pathol. 155:739–752. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Paulis YW, Soetekouw PM, Verheul HM,
Tjan-Heijnen VC and Griffioen AW: Signalling pathways in
vasculogenic mimicry. Biochim Biophys Acta. 1806:18–28.
2010.PubMed/NCBI
|
|
3
|
Kirschmann DA, Seftor EA, et al: Molecular
pathways: vasculogenic mimicry in tumor cells: diagnostic and
therapeutic implications. Clin Cancer Res. 18:2726–2732. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mohla S: Tumor microenvironment. J Cell
Biochem. 101:801–804. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Florczyk SJ, Wang K, Jana S, et al: Porous
chitosan-hyaluronic acid scaffolds as a mimic of glioblastoma
microenvironment ECM. Biomaterials. 34:10143–10150. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tafani M, Di Vito M, et al:
Pro-inflammatory gene expression in solid glioblastoma
microenvironment and in hypoxic stem cells from human glioblastoma.
J Neuroinflammation. 8:32–40. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Heddleston JM, Wu Q, Rivera M, et al:
Hypoxia-induced mixed-lineage leukemia 1 regulates glioma stem cell
tumorigenic potential. Cell Death Differ. 19:428–439. 2012.
View Article : Google Scholar
|
|
8
|
Scully S, Francescone R, Faibish M, et al:
Transdifferentiation of glioblastoma stem-like cells into mural
cells drives vasculogenic mimicry in glioblastomas. J Neurosci.
32:12950–12960. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gariboldi MB, Ravizza R and Monti E: The
IGFR1 inhibitor NVP-AEW541 disrupts a pro-survival and
pro-angiogenic IGF-STAT3-HIF1 pathway in human glioblastoma cells.
Biochem Pharmacol. 80:455–462. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Neelam S, Brooks MM and Cammarata PR:
Lenticular cytoprotection. Part 1: the role of hypoxia inducible
factors-1α and -2α and vascular endothelial growth factor in lens
epithelial cell survival in hypoxia. Mol Vis. 19:1–15. 2013.
|
|
11
|
Kucharzewska P, Christianson HC, Welch JE,
et al: Exosomes reflect the hypoxic status of glioma cells and
mediate hypoxia-dependent activation of vascular cells during tumor
development. Proc Natl Acad Sci USA. 110:7312–7317. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nissou MF, El Atifi M, Guttin A, et al:
Hypoxia-induced expression of VE-cadherin and filamin B in glioma
cell cultures and pseudopalisade structures. J Neurooncol.
113:239–249. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Biroccio A, Candiloro A, Mottolese M, et
al: Bcl-2 overpression and hypoxia synergistically act to modulate
vascular endothelial growth factor expression and in vivo
angiogenesis in a breast carcinoma line. FASEB J. 14:652–660.
2000.PubMed/NCBI
|
|
14
|
Reed JC: Bcl-2-family proteins and
hematologic malignancies: history and future prospects. Blood.
111:3322–3330. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yip KW and Reed JC: Bcl-2 family proteins
and cancer. Oncogene. 27:6398–6406. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sood AK, Fletcher MS, Zahn CM, et al: The
clinical significance of tumor cell-lined vasculature in ovarian
carcinoma-: iImplications for anti-vasculogenic therapy. Cancer
Biol Ther. 1:661–664. 2002. View
Article : Google Scholar
|
|
17
|
Shirakawa K, Kobayashj H, et al:
Inflammatory breast cancer: vasculogenic mimicry and its
hemodynamics of an inflammatory breast cancer xenograft model.
Breast Cancer Res. 5:136–139. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Guzman G, Cotler SJ, Lin AY, et al: A
pilot study of vasculogenic mimicry immunohistochemical expression
in hepatocellular carcinoma. Arch Pathol Lab Med. 131:1776–1781.
2007.PubMed/NCBI
|
|
19
|
Fujimoto A, Onodera H, Mori A, et al:
Tumor plasticity and extravascular circulation in EVC304 human
bladder carcinoma cells. Anticancer Res. 26:59–69. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Guzman G, Cotler SJ, et al: A pilot study
of vasculogenic mimicry immunohistochemical expression in
hepatocellular carcinoma. Arch Pathol Lab Med. 131:1776–1781.
2007.PubMed/NCBI
|
|
21
|
Wohlfart P, Malinski T, Ruetten H, et al:
Release of nitric oxide from endothelial cells stimulated by YC-1,
an activator of soluble guanylyl cyclase. Br J Pharmacol.
128:1316–1322. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
El Hallani S, Boisselier B, Peglion F, et
al: A new alternative mechanism in glioblastoma vascularization:
tubular vasculogenic mimicry. Brain. 133:973–982. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Vaupel P and Mayer A: Hypoxia in cancer:
significance and impact on clinical outcome. Cancer Metastasis Rev.
26:225–239. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ahluwalia A and Tarnawski AS: Critical
role of hypoxia sensor - HIF-1α in VEGF gene activation.
Implications for angiogenesis and tissue injury healing. Curr Med
Chem. 19:90–97. 2012. View Article : Google Scholar
|
|
25
|
EI Hallani S, Boisselier B, Peglion F, et
al: A new alternative mechanism in glioblastoma vascularization:
tubular vasculogenic mimicry. Brain. 133:973–982. 2010. View Article : Google Scholar
|
|
26
|
Youle RJ and Strasser A: The BCL-2 protein
family: opposing activities that mediate cell death. Nat Rev Mol
Cell Biol. 9:47–59. 2008. View
Article : Google Scholar
|
|
27
|
Zhao N, Sun BC, Sun T, et al:
Hypoxia-induced vasculogenic mimicry formation via VE-cadherin
regulation by Bcl-2. Med Oncol. 29:3599–3607. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jain RK, di Tomaso E, Duda DG, et al:
Angiogenesis in brain tumours. Nat Rev Neurosci. 8:610–622. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sullivan R, Paré GC, Frederiksen LJ,
Semenza GL and Graham CH: Hypoxia-induced resistance to anticancer
drug is associated with decreased senescence and requires
hypoxia-inducible factor-1 activity. Mol Cancer Ther. 7:1961–1973.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mak P, Leav I, Pursell B, et al: ERbeta
impedes prostate cancer EMT by destabilizing HIF-1alpha and
inhibiting VEGF mediated snail nuclear localization: implications
for Gleason grading. Cancer Cell. 17:319–332. 2010. View Article : Google Scholar : PubMed/NCBI
|
